Products and services: hormone replacement therapy
The menopausal transition is a natural phase in a woman’s life which generally occurs between the ages of 45 and 55, when production of the hormones oestrogen and progesterone gradually ceases. Women frequently suffer from significant complaints such as hot flushes, night sweats, sleep disorders, mood swings, and dryness of the vagina or other mucous membranes. Over time, the hormonal deficiency can also lead to an increased risk of fractures due to osteoporosis.
Hormone replacement therapy is the most effective treatment for climacteric symptoms of women in different stages of the menopausal transition. Nowadays, women suffering from climacteric symptoms can choose well-tolerated and efficacious low-dose hormone replacement preparations.
Novo Nordisk is one of the world's largest manufacturers of hormone replacement products, offering a range of low-dose medicines for the effective treatment of menopausal symptoms tailored to the individual needs of women:
Activelle® - a low-dose oral continuous combined HRT for the early initiation of an effective bleed-free treatment.
Novofem® - a low-dose oral sequential combined HRT for the early initiation of an effective treatment with regular withdrawal bleeding.
Estrofem® - an oestrogen-only therapy for women who have undergone a hysterectomy.
Vagifem® - a local oestrogen therapy for symptoms associated with vaginal dryness such as painful intercourse, itching, burning and soreness.
This page has been assessed by PricewaterhouseCoopers as part of its assessment of Novo Nordisk’s statement that it reports ‘in accordance’ with GRI. Please refer to Audit and assurance for a full description of the nature of assurance offered.
